Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B

NCT00291616 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Pegylated Interferon-alpha2a
DRUG: Thymosin alpha1 & Pegylated Interferon-alpha2a

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]